This collaboration provides an opportunity to support future initiatives such as medical education through the IDF School of Diabetes
Gan & Lee Pharmaceuticals Co, Ltd, a global biopharmaceutical company based in China, has announced a collaboration with the International Diabetes Federation (IDF) to support its global efforts to advance diabetes care and prevention worldwide.
This collaboration offers the opportunity to support future initiatives such as medical education through the IDF School of Diabetes and to become the first partner in the launch of the IDF WeChat platform in China.
This partnership also offers the opportunity to participate in advocacy initiatives such as World Diabetes Day and the 100th Anniversary of Insulin.
“Gan & Lee’s collaboration with IDF provides an opportunity to support global outreach and advocacy initiatives to improve the lives of people with diabetes,” said Kai Du, CEO of Gan & Lee Pharmaceuticals, chairman of Gan & Lee USA Corporation.
“The International Diabetes Federation is excited to partner with Gan & Lee in support of our global awareness, advocacy and education initiatives. In a year marking the 100th anniversary of the discovery of insulin, coordinated and collaborative efforts to bring about Providing affordable and uninterrupted care education for everyone living with diabetes, regardless of where they live or economic situation, is more important than ever, “said Prof. Andrew Boulton, President of the International Diabetes Federation.
